Newer modalities in otitis media

Abstract

Otitis media continues to be one of the most frequent causes of outpatient visits, antibiotic prescriptions, and surgery in India, but there has been little advancement in the creation of new therapies for the prevention and treatment of this disorder, highlighting the urgent need for further research into the pathophysiology of this condition. New management guidelines for acute otitis media, chronic otitis media, and tympanostomy tube implantation have just been published. Exciting new technologies are being researched into creative ways to enhance the diagnosis of otitis media, as discussed in this article. Recent developments in mucosal immunology and genetics have provided hints about the pathophysiology underlining the predisposition for otitis media. Future work aimed at altering these pathophysiologic bases, maybe through transtympanic drug delivery devices, should have a significant impact on how this illness is managed. Recent years have witnessed significant advancements in the study of innovative approaches to the pathophysiology, diagnosis, and therapy of otitis media. Within the next few years, it's expected that approaches to significantly changing the diagnosis and treatment of the ailment will be integrated into clinical practise.